Month: August 2025

WARREN, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) — Tevogen Bio Holdings Inc. (“Tevogen” or the “Company) (Nasdaq: TVGN), reiterates investor confidence and estimated asset value over $10 billion. In October 2024, HMP Partners and The Patel Family LLP, investors in innovative healthcare ventures, congratulated Tevogen Bio and Dr. Ryan Saadi for their efforts to alleviate health inequality through breakthrough life-saving medical innovations. Hema Patel, Managing Partner of HMP Partners and The Patel Family LLP, remarked, “We are impressed by Leadership’s extensive industry experience resulting in achieving key milestones in record times including granted patents and a product pipeline in multiple therapeutic areas. In 2022, Tevogen Bio was named as the highest-valued biotech unicorn at $4.2 billion.” Speaking to the Company’s...

LONDON, Aug. 11, 2025 (GLOBE NEWSWIRE) — Qualstar Corporation (OTC: Markets: QBAK), a leading manufacturer of data storage solutions and high-efficiency power supplies, today announced its partnership with CMS Distribution. The partnership will allow CMS to distribute Qualstar’s data storage products to corporate resellers, managed service providers, high street and online retailers, and multi-national and independent IT companies. Qualstar is meeting the next generation data needs with intelligent storage solutions, providing products to customers in media and entertainment, oil and gas, government and military, education, IT, medical imaging, banking, surveillance, and data centers. The Qualstar AdvantageImmediate availability-most libraries ship within 3-5 business days Pre-configured to customers exact requirements and tested...

DENVER, Aug. 11, 2025 (GLOBE NEWSWIRE) — EverCommerce Inc. (NASDAQ: EVCM), a leading provider of SaaS solutions for service SMBs, today announced that management will present at the following upcoming investor conferences:Chief Executive Officer Eric Remer will present at the Oppenheimer 28th Annual Technology, Internet & Communications Conference. The presentation is scheduled for Tuesday, August 12, 2025, at 12:25 p.m. EST.Chief Financial Officer Ryan Siurek and SVP, Finance, & Head of Investor Relations Brad Korch will present and participate in 1×1 meetings at the Canaccord Genuity 45th Annual Growth Conference in Boston on Wednesday, August 13, 2025. The presentation is at 9:30a.m. EST.SVP, Finance, & Head of Investor Relations Brad Korch will participate in 1×1 meetings at the Deutsche Bank...

Group Business Leaders Established; Functional Leaders Responsibilities Enhanced Ashis Bhattacharya to Retire EDEN PRAIRIE, Minn., Aug. 11, 2025 (GLOBE NEWSWIRE) — Winnebago Industries, Inc. (NYSE: WGO) today announced several key changes to its executive leadership team, including newly created group leader roles. The announcement comes as the company continues to take strategic actions that further enhance its position as the trusted leader in the premium outdoor recreation market and drive its next phase of growth.   “These changes are designed to help us stay agile, support future growth and leverage the strong leadership talent we have across the company,” said Winnebago Industries President and CEO, Michael Happe. “Most importantly, they’re about continuing to serve our customers, supporting our employees and delivering value...

Treatment of a subgroup of patients with post-acute sequelae of SARS-CoV-2. Forecast adds to Tevogen Bio’s Oncology therapeutic area projections of $1 billion in the launch year and $10–$14 billion over the first five years.WARREN, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) — Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, today announced its top-line revenue forecast for its specialty care pipeline, projecting nearly $1 billion in revenue in its launch year and a cumulative 5-year estimate of between $18 billion and $22 billion. This forecast reflects the company’s unique, faster, and cost-efficient drug development model which has the potential...

La Hulpe, Belgium – 11 August 2025, 7:00 p.m. CEST – Banqup Group SA, formerly Unifiedpost Group SA, (Euronext: BANQ) (Banqup, Company), a leading provider of integrated business communications solutions, today announced the completion of the sale of its UK print operations to the Managing Director of the UK business.  The sale of the UK print business aligns with our strategic priority to rationalise the portfolio through the divestment of non-core, traditional communication services. This reinforces our focus on growing core digital services. The new ownership structure ensures a seamless transition with continuity maintained for employees and customers. As part of the transaction, a strategic partnership agreement has been signed whereby the UK print business will become an authorised reseller of Banqup products. The financial...

Total eligible patients in the US exceed 2 million. Treatment of SARS-CoV-2 infection in solid and hematologic cancer patients under active treatment. Reflects business philosophy of commercial success through patient accessibility.WARREN, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) — Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, today announced its top-line revenue forecast for its oncology pipeline, projecting $1 billion in revenue in its launch year and a cumulative 5-year estimate of between $10 billion and $14 billion. This forecast reflects the company’s unique, faster, and cost-efficient drug development model which has the potential to serve as...

        RELEASE                           DISCLOSURE OF TRADING IN OWN SHARES FROM AUGUST 4 TO AUGUST 8, 2025 In accordance with the authorization granted by the Shareholders’ Meeting in order to trade in own shares and pursuant to applicable law on share repurchases, Rexel declares the following purchases of its own shares from August 4 to August 8, 2025:Name of the issuer Identity code of the issuer (Legal Entity Identifier) Day of transaction Identity code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code)REXEL 969500N6AVPA51648T62 04/08/2025 FR0010451203 1 000 25,95 CCXEREXEL 969500N6AVPA51648T62 04/08/2025 FR0010451203 68 25,83 TQEXREXEL 969500N6AVPA51648T62 04/08/2025 FR0010451203 30 470 26,01321 XPARREXEL 969500N6AVPA51648T62 05/08/2025 FR0010451203 ...

VAISALA CORPORATION STOCK EXCHANGE RELEASE 11.8.2025          Vaisala Corporation: Share Repurchase 11.8.2025       In the Helsinki Stock Exchange         Trade date           11.8.2025  Bourse trade         Buy  Share                  VAIAS  Amount             1 000 SharesAverage price/ share    46,9768 EURTotal cost            46 976,80 EUR          Vaisala Corporation now holds a total of 135 826 sharesincluding the shares repurchased on 11.8.2025       The share buybacks are executed in compliance with Regulation No. 596/2014 of the European Parliament and Council (MAR) Article 5and the Commission Delegated Regulation (EU) 2016/1052.     On behalf of Vaisala Corporation         Nordea Bank Oyj         Sami Huttunen Ilari Isomäki       More information:Niina...

INFORMATION REGARDING EXECUTED TRANSACTIONS WITHIN THE FRAMEWORK OF A SHARE BUY-BACK PROGRAM Regulated Information Paris, 11 August 2025 (In accordance with article 5 of Regulation (EU) No 596/2014 on Market Abuse Regulation and article 3(3) of Delegated Regulation (EU) 2016/1052 supplementing Regulation (EU) No 596/2014 through regulatory technical standards concerning the conditions applicable to buy-back programs and stabilization measures) As announced on Thursday 31 July 2025, Societe Generale started on Monday 4 August 2025 a EUR 1 billion ordinary share buy-back program for the purpose of shares cancellation. Societe Generale received all necessary authorizations from supervisory authorities. These buy-backs are carried out in compliance with the conditions, notably regarding the maximum price, set forth by the General Meeting of...